Amgen : AMGN

All Amgen Articles

720 Articles

Jon C. Ogg | Jan 25, 2013 at 8:38 AM EST

Top Analyst Upgrades and Downgrades (ATK, AMZN, AMCX, AMGN, AAPL, ADSK, EBAY, FLEX, JNS, ORCL, TIF, WPRT, GS, JPM, UBS)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Friday.…

Paul Ausick | Jan 24, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 24, 2013: Markets Mixed After Apple Earnings (AAPL, PG, EMR, CVS, GOLD, TIF, AMGN, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RTN, LUV, UNP, UAL, XRX, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, NOK, NFLX, SWFT)

U.S. equity markets opened mixed this morning with the DJIA and the S&P 500 higher, and the Nasdaq lower, dragged…

Paul Ausick | Jan 23, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

U.S. equity markets opened higher this morning following a string of solid earnings reports yesterday and after markets closed last…

Paul Ausick | Jan 23, 2013 at 1:28 PM EST

Earnings Preview for Today: AMGN, AAPL, NFLX, SNDK

thinkstock Today got off to a bit of a rocky start on earnings. McDonald’s Corp. (NYSE: MCD) beat estimates but…

Jon C. Ogg | Jan 22, 2013 at 8:14 AM EST

Top Analyst Upgrades and Downgrades (AMGN, ARMH, BBVA, CHTR, CMCSA, GLW, DTV, DO, DISH, ET, FE, JCP, LRCX, LIFE, LNKD, PBF, SCHS, SLB, SYMC, TIF, TWC, WCC)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…

Jon C. Ogg | Jan 18, 2013 at 12:10 PM EST

Major Earnings on Deck the Week Ahead for DJIA and S&P Stocks

The week ahead will be the official flood gate opening for earnings season. We have a very large portion of the…

Jon C. Ogg | Jan 18, 2013 at 9:50 AM EST

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is…

Jon C. Ogg | Jan 14, 2013 at 10:04 AM EST

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

ThinkstockCancer ranks on the list of global killers as number two. Over the years, great strides have been made not only…

Jon C. Ogg | Jan 9, 2013 at 7:27 AM EST

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the…

Jon C. Ogg | Jan 8, 2013 at 2:39 PM EST

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

ThinkstockAmgen Inc. (NASDAQ: AMGN) is holding up better than some investors might have expected after the biotech giant warned about…

Jon C. Ogg | Dec 20, 2012 at 2:57 PM EST

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

The largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013.…

Paul Ausick | Dec 14, 2012 at 8:09 AM EST

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

ThinkstockBiotech giant Amgen Inc. (NASDAQ: AMGN) made a series of moves after markets closed last night that appear to add…

Jon C. Ogg | Dec 12, 2012 at 8:36 AM EST

Top Analyst Upgrades and Downgrades (ALGN, AMGN, C, DYN, FDX, MFRM, MDLZ, NKE, OPEN, ORCL, POT, MOS, PB, STX, TTWO, TEVA, UA, VOLC, YELP)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday.…

Trey Thoelcke | Nov 12, 2012 at 8:04 AM EST

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Jon C. Ogg | Nov 6, 2012 at 6:20 AM EST

Five Big Dividend Hikes Expected Very Soon

ThinkstockDividend stocks may have come under some pressure of late, but this is due to the demand for high dividends…

1 … 34 35 36 37 38 … 48

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades (ATK, AMZN, AMCX, AMGN, AAPL, ADSK, EBAY, FLEX, JNS, ORCL, TIF, WPRT, GS, JPM, UBS)

24/7 Wall St. Closing Bell — January 24, 2013: Markets Mixed After Apple Earnings (AAPL, PG, EMR, CVS, GOLD, TIF, AMGN, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RTN, LUV, UNP, UAL, XRX, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, NOK, NFLX, SWFT)

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

Earnings Preview for Today: AMGN, AAPL, NFLX, SNDK

Top Analyst Upgrades and Downgrades (AMGN, ARMH, BBVA, CHTR, CMCSA, GLW, DTV, DO, DISH, ET, FE, JCP, LRCX, LIFE, LNKD, PBF, SCHS, SLB, SYMC, TIF, TWC, WCC)

Major Earnings on Deck the Week Ahead for DJIA and S&P Stocks

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

Top Analyst Upgrades and Downgrades (ALGN, AMGN, C, DYN, FDX, MFRM, MDLZ, NKE, OPEN, ORCL, POT, MOS, PB, STX, TTWO, TEVA, UA, VOLC, YELP)

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Five Big Dividend Hikes Expected Very Soon

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn't Paid Capital-Gains Tax Since.

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades and Downgrades (ATK, AMZN, AMCX, AMGN, AAPL, ADSK, EBAY, FLEX, JNS, ORCL, TIF, WPRT, GS, JPM, UBS)

24/7 Wall St. Closing Bell — January 24, 2013: Markets Mixed After Apple Earnings (AAPL, PG, EMR, CVS, GOLD, TIF, AMGN, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RTN, LUV, UNP, UAL, XRX, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, NOK, NFLX, SWFT)

24/7 Wall St. Closing Bell — January 23, 2013: Market Open Higher on Little News (COST, GE, VZ, F, INCY, AMD, CSX, GOOG, IBM, IGT, TXN, ABT, BHI, COH, GD, MCD, LCC, AAPL, AMGN, NFLX, SNDK, FFIV, NE, NVR, WDC, MMM, BMY, LMT, RYN, LUV, UNP, UAL, XRX, MAPP, AGN, NMRX, MCP)

Earnings Preview for Today: AMGN, AAPL, NFLX, SNDK

Top Analyst Upgrades and Downgrades (AMGN, ARMH, BBVA, CHTR, CMCSA, GLW, DTV, DO, DISH, ET, FE, JCP, LRCX, LIFE, LNKD, PBF, SCHS, SLB, SYMC, TIF, TWC, WCC)

Major Earnings on Deck the Week Ahead for DJIA and S&P Stocks

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

More Hope for Cancer Vaccines in 2013 (UBS, GSK, DNDN, AMGN)

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Investors Ignore Amgen Earnings Warning Due To R&D Tax-Credit

How Overvalued Are the Biggest Biotechs? (AMGN, BIIB, GILD, ALXN)

Amgen Shakes Things Up: Dividend Boost, New Chairman, Share Buybacks

Top Analyst Upgrades and Downgrades (ALGN, AMGN, C, DYN, FDX, MFRM, MDLZ, NKE, OPEN, ORCL, POT, MOS, PB, STX, TTWO, TEVA, UA, VOLC, YELP)

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Five Big Dividend Hikes Expected Very Soon

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.

Social Security’s $184,500 Wage Cap Is Under Fire. Here’s Exactly Who Would Pay More

Featured Reads

Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.

He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn't Paid Capital-Gains Tax Since.